FOXO Technologies
- Company typePublic
- Founded2020
- HeadquartersMinneapolis, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
FOXO Technologies firmographics
Firmographics- Name
- FOXO Technologies
- Legal name
- FOXO Technologies, Inc.
- Website
- https://foxotechnologies.com
- Company type
- Public
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where FOXO Technologies is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
FOXO Technologies business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Revenue model
- Healthcare Operations Revenue: Revenue generated from operating three synergistic divisions: epigenetic diagnostics and interpretation, rural hospitals, and mental and behavioral health facilities. Includes Myrtle Recovery Centers, Big South Fork Medical, and Rennova Community Health.
- Royalty from Licensing: 3% royalty on net revenues from LongevityFP Technologies, LLC commercialization of epigenetics technology, capped at $1.3 million
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
FOXO Technologies product offering
Product offeringCore offering
FOXO Technologies, Inc. is a healthcare services and technology company that operates three synergistic divisions through wholly owned subsidiaries: (1) epigenetic diagnostics and interpretation using proprietary biomarker IP and AI-based solutions for human health and longevity, (2) rural hospitals providing community health and clinical services in Tennessee (Rennova Community Health and Big South Fork Medical), and (3) mental and behavioral health facilities providing inpatient and outpatient addiction treatment (Myrtle Recovery Centers). The company also operates Vector BioSource for biospecimen sourcing for biotech, clinical, and pharmaceutical research.
Differentiator
Problem solved
Functional benefit
Brands
- Rennova Community Health: Rural hospital services division operating hospitals and medical facilities in Tennessee.
- Big South Fork Medical
- Myrtle Recovery Centers
- Vector BioSource
- Epigenetics
Products and services
- Epigenetics Diagnostics and Interpretation Services Epigenetic diagnostics and interpretation services that use proprietary biomarker technology and AI-based solutions to assess biological aging and human health/longevity. The underlying IP includes two patents and related intellectual property held by subsidiary FOXO Labs Inc.
- Myrtle Recovery Centers Inpatient and outpatient behavioral health and addiction treatment facility in East Tennessee providing substance abuse treatment services, operated by wholly owned subsidiary Myrtle Recovery Centers, Inc. Licensed by the Tennessee Department of Mental Health and Substance Abuse Services.
- Rennova Community Health, Inc. Rural hospital services and community health operations acquired from Rennova Health, Inc., providing acute care and clinical hospital services in Tennessee. Operated by wholly owned subsidiary Rennova Community Health, Inc.
- Big South Fork Medical Rural hospital facility providing clinical healthcare services in Tennessee, operated by wholly owned subsidiary Big South Fork Medical (formerly Scott County Community Hospital). Has a performance network agreement with Covenant Health for swing bed services.
- Vector BioSource Biospecimen sourcing services provider for the biotechnology, clinical research, and pharmaceutical research industries, operated by wholly owned subsidiary Vector BioSource Inc. (closed 2025-09-22).
- Bioinformatics Services Platform Bioinformatics services platform launched in July 2023 to accelerate epigenetic data analysis for research and biotechnology customers.
Quantifiable outcome
- Myrtle Recovery Centers expected to generate $3-4 million annually
- +1 more outcomes
Companies that use FOXO Technologies
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
FOXO Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature2 records
FOXO Technologies partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- LongevityFP Technologies, LLCcoreExclusive license agreement to commercialize FOXO's epigenetics technology including two patents and related intellectual property. LFP will pay FOXO a 3% royalty on net revenues capped at $1.3 million. LFP has been granted a ten-year option to acquire majority ownership of FOXO Labs Inc. The partnership reunites the technology with its original inventor and architect, Jon R. Sabes.
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
FOXO Technologies competitors and assessment
Company assessmentDirect peers
- Rennova Health: Rennova Health is the seller of FOXO's rural hospital and behavioral health assets and shares CEO Seamus Lagan; effectively FOXO's closest operating peer with overlapping rural hospital and addiction treatment exposure.
- Acadia Healthcare: Acadia Healthcare operates the largest network of behavioral health facilities in the US including addiction treatment — directly comparable to FOXO's Myrtle Recovery Centers behavioral health vertical.
- Universal Health Services: UHS operates acute care and behavioral health hospitals nationwide, making it the closest diversified peer to FOXO's combined rural hospital + behavioral health operating model.
- Spero Health: Spero Health operates outpatient addiction treatment and recovery services across multiple US states; comparable to Myrtle Recovery Centers' inpatient/outpatient behavioral health model.
- TruDiagnostic: TruDiagnostic is an epigenetic diagnostics company offering biological age testing and methylation-based health assessments — directly comparable to FOXO Labs' epigenetic biomarker platform.
- Elysium Health: Elysium Health develops consumer longevity products grounded in epigenetic and cellular health science — a direct peer to FOXO's longevity and epigenetic diagnostics positioning.
Broad incumbents
- Magellan Health: Magellan Health is a larger managed-care and behavioral health services company serving health plans and employers — a broad incumbent with overlapping behavioral health capabilities but a different delivery model.
- Illumina: Illumina is the dominant DNA sequencing and methylation technology platform — relevant as the broad incumbent in the epigenetic technology stack underpinning FOXO Labs' biomarkers (and FOXO's Chairman is an Illumina bioinformatics scientist).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
FOXO Technologies social profiles
Digital presenceFOXO Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
FOXO Technologies leadership team
Management profileNumber of profiles
Profiles5 records
FOXO Technologies subsidiaries and ownership
Company hierarchySubsidiaries5 records
FOXO Technologies funding detail
Funding detailFunding overview
Funding rounds7 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FOXO Technologies M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FOXO Technologies
What does FOXO Technologies do?
FOXO Technologies, Inc. is a healthcare services and technology company that operates three synergistic divisions through wholly owned subsidiaries: (1) epigenetic diagnostics and interpretation using proprietary biomarker IP and AI-based solutions for human health and longevity, (2) rural hospitals providing community health and clinical services in Tennessee (Rennova Community Health and Big South Fork Medical), and (3) mental and behavioral health facilities providing inpatient and outpatient addiction treatment (Myrtle Recovery Centers). The company also operates Vector BioSource for biospecimen sourcing for biotech, clinical, and pharmaceutical research.
Is FOXO Technologies a public or private company?
FOXO Technologies is a public company. It is classified as public and is currently operating.
When was FOXO Technologies founded?
FOXO Technologies was founded in 2020. It employs 1 to 10 people.
Where is FOXO Technologies based?
FOXO Technologies is headquartered in Minneapolis, United States, in the North America region.
How does FOXO Technologies make money?
Two revenue lines are on record. Healthcare Operations Revenue is the primary driver. The others are royalty from Licensing.
Who are FOXO Technologies's main competitors?
Direct peers on record are Rennova Health, Acadia Healthcare, Universal Health Services, Spero Health, TruDiagnostic and Elysium Health. Broad incumbents are Magellan Health and Illumina.
Does FOXO Technologies have an API?
No public API is recorded for FOXO Technologies.